Case studies of spinal cord injury patients treated with CD34+ and mesenchymal stem cells harvested from human umbilical cord Wharton’s jelly and cord blood, animal studies using mesenchymal stem cells, immunosuppression requirements in allogeneic stem cell treatments, intrathecal and intravenous administration of autologous bone marrow stem cells in spinal cord injury patients, and the role adult stem cell trophic factors in tissue regeneration.
Neil Riordan PhD – Stem cell therapy for spinal cord injury (part 2 of 5)
Reviewed By:
Verónica Gaez, M.D.
Staff Physician
Dr. Gaez specializes in anti-aging, orthomolecular medicine, and hospital management, with a focus on regenerative medicine and stem cell therapy. She earned her medical degree in 2015 and holds a research certification from Hospital del Niño de Panamá.